A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT01875705 · COMPLETED
Trial details
- NCT number
- NCT01875705
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-21
- Primary completion
- 2016-09-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.